Literature DB >> 24509835

Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.

Silke Nuber1, Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle, Kori Kosberg, Michael Mante, Edward Rockenstein, Margarita Trejo, Eliezer Masliah.   

Abstract

The olfactory bulb (OB) is one of the first brain regions in Parkinson's disease (PD) to contain alpha-synuclein (α-syn) inclusions, possibly associated with nonmotor symptoms. Mechanisms underlying olfactory synucleinopathy, its contribution to progressive aggregation pathology and nigrostriatal dopaminergic loss observed at later stages, remain unclear. A second hit, such as environmental toxins, is suggestive for α-syn aggregation in olfactory neurons, potentially triggering disease progression. To address the possible pathogenic role of olfactory α-syn accumulation in early PD, we exposed mice with site-specific and inducible overexpression of familial PD-linked mutant α-syn in OB neurons to a low dose of the herbicide paraquat. Here, we found that olfactory α-syn per se elicited structural and behavioral abnormalities, characteristic of an early time point in models with widespread α-syn expression, including hyperactivity and increased striatal dopaminergic marker. Suppression of α-syn reversed the dopaminergic phenotype. In contrast, paraquat treatment synergistically induced degeneration of olfactory dopaminergic cells and opposed the higher reactive phenotype. Neither neurodegeneration nor behavioral abnormalities were detected in paraquat-treated mice with suppressed α-syn expression. By increasing calpain activity, paraquat induced a pathological cascade leading to inhibition of autophagy clearance and accumulation of calpain-cleaved truncated and insoluble α-syn, recapitulating biochemical and structural changes in human PD. Thus our results underscore the primary role of proteolytic failure in aggregation pathology. In addition, we provide novel evidence that olfactory dopaminergic neurons display an increased vulnerability toward neurotoxins in dependence to presence of human α-syn, possibly mediating an olfactory-striatal dopaminergic network dysfunction in mouse models and early PD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509835      PMCID: PMC4324760          DOI: 10.1007/s00401-014-1255-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  108 in total

1.  Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology.

Authors:  Ayse Ulusoy; Fabia Febbraro; Poul H Jensen; Deniz Kirik; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2010-08       Impact factor: 3.386

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 3.  Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.

Authors:  Tito Calì; Denis Ottolini; Marisa Brini
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

4.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

5.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

6.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

Review 7.  Olfaction and Parkinson's syndromes: its role in differential diagnosis.

Authors:  Regina Katzenschlager; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

8.  A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.

Authors:  Alexander Kurz; Kay L Double; Isabel Lastres-Becker; Alessandro Tozzi; Michela Tantucci; Vanessa Bockhart; Michael Bonin; Moisés García-Arencibia; Silke Nuber; Falk Schlaudraff; Birgit Liss; Javier Fernández-Ruiz; Manfred Gerlach; Ullrich Wüllner; Hartmut Lüddens; Paolo Calabresi; Georg Auburger; Suzana Gispert
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

9.  Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.

Authors:  Nicolas Casadei; Anne-Maria Pöhler; Cristina Tomás-Zapico; Jesús Torres-Peraza; Ivo Schwedhelm; Annemarie Witz; Irina Zamolo; Raymond De Heer; Berry Spruijt; Lucas P J J Noldus; Jochen Klucken; José J Lucas; Philipp J Kahle; Rejko Krüger; Olaf Riess; Silke Nuber
Journal:  Hum Mol Genet       Date:  2013-09-24       Impact factor: 6.150

10.  p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions.

Authors:  Yoshihisa Watanabe; Harutsugu Tatebe; Katsutoshi Taguchi; Yasuhisa Endo; Takahiko Tokuda; Toshiki Mizuno; Masanori Nakagawa; Masaki Tanaka
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  15 in total

1.  Caspase-1 clipping causes complications for α-synuclein.

Authors:  Silke Nuber; Dennis J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

2.  Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

Authors:  Meike Diepenbroek; Nicolas Casadei; Hakan Esmer; Takaomi C Saido; Jiro Takano; Philipp J Kahle; Ralph A Nixon; Mala V Rao; Ronald Melki; Laura Pieri; Stefan Helling; Katrin Marcus; Rejko Krueger; Eliezer Masliah; Olaf Riess; Silke Nuber
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

Review 3.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

Review 4.  Mechanisms of Gene-Environment Interactions in Parkinson's Disease.

Authors:  Sheila M Fleming
Journal:  Curr Environ Health Rep       Date:  2017-06

5.  Clathrin-Dependent Uptake of Paraquat into SH-SY5Y Cells and Its Internalization into Different Subcellular Compartments.

Authors:  Fengrui Li; Xiaofei Tian; Xiaoni Zhan; Baojie Wang; Mei Ding; Hao Pang
Journal:  Neurotox Res       Date:  2017-03-16       Impact factor: 3.911

6.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

Review 7.  Therapeutic approaches in Parkinson's disease and related disorders.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

8.  Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.

Authors:  Benjamin Ettle; Simone Reiprich; Janina Deusser; Johannes C M Schlachetzki; Wei Xiang; Iryna Prots; Eliezer Masliah; Beate Winner; Michael Wegner; Jürgen Winkler
Journal:  Mol Cell Neurosci       Date:  2014-07-11       Impact factor: 4.314

9.  Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.

Authors:  J Scott Miners; Ruth Renfrew; Marta Swirski; Seth Love
Journal:  Acta Neuropathol Commun       Date:  2014-12-05       Impact factor: 7.801

10.  Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.

Authors:  Silke Nuber; Molly Rajsombath; Georgia Minakaki; Jürgen Winkler; Christian P Müller; Maria Ericsson; Barbara Caldarone; Ulf Dettmer; Dennis J Selkoe
Journal:  Neuron       Date:  2018-10-10       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.